Correlation Between NYSE Composite and Reneo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Reneo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Reneo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Reneo Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and Reneo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Reneo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Reneo Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Reneo Pharmaceuticals
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NYSE and Reneo is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Reneo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reneo Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Reneo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reneo Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Reneo Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Reneo Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 5.42 times less return on investment than Reneo Pharmaceuticals. But when comparing it to its historical volatility, NYSE Composite is 4.38 times less risky than Reneo Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Reneo Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 1,510 in Reneo Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of 310.00 from holding Reneo Pharmaceuticals or generate 20.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 55.56% |
Values | Daily Returns |
NYSE Composite vs. Reneo Pharmaceuticals
Performance |
Timeline |
NYSE Composite and Reneo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Reneo Pharmaceuticals
Pair trading matchups for Reneo Pharmaceuticals
Pair Trading with NYSE Composite and Reneo Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Reneo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Reneo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reneo Pharmaceuticals will offset losses from the drop in Reneo Pharmaceuticals' long position.NYSE Composite vs. Delek Logistics Partners | NYSE Composite vs. Sun Country Airlines | NYSE Composite vs. China Clean Energy | NYSE Composite vs. Regeneron Pharmaceuticals |
Reneo Pharmaceuticals vs. Prime Medicine, Common | Reneo Pharmaceuticals vs. Ginkgo Bioworks Holdings | Reneo Pharmaceuticals vs. Ocean Biomedical | Reneo Pharmaceuticals vs. Royalty Pharma Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Bonds Directory Find actively traded corporate debentures issued by US companies |